73°F
weather icon Clear
FDA delaying decision on Moderna shot for adolescents

U.S. regulators are delaying their decision on Moderna’s COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday.